{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:40:03Z","timestamp":1779165603591,"version":"3.51.4"},"reference-count":46,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Intramural Research Program of the National Institutes of Health"},{"name":"Noah's Ark and Weiss Family CAH Research Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Children with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency typically have height, weight, and body mass index (BMI) growth patterns that differ from the general population due to increased androgen and\/or glucocorticoid exposures. With the recent surge in the development of new therapies, CAH-specific growth charts are needed to evaluate the effectiveness of these new treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective data from patients aged 0 to 20 years with classic CAH, confirmed by hormonal testing and\/or CYP21A2 genotyping, from 2 large clinical databases were analyzed. Specialized charts were developed using the lamda-mu-sigma semiparametric modeling method to generate CAH-specific percentile curves from 0 to 20 years. Nodal-point analyses were conducted to assess differences in incremental growth at 4, 8, 12, 16, and 20 years of age relative to Centers for Disease Control and Prevention (CDC) 2000 normative charts using 1-sided quantile tests and age of adiposity rebound estimated with curve derivative solutions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total sample of 8692 visits from 515 patients was used. Growth (height-, weight-, BMI-for-age) channels of CAH patients were significantly different over the entire growing period and characterized by diminished pubertal spurt relative to the CDC reference. Onset of adiposity rebound based on BMI-for-age occurred earlier for CAH patients (females 3.3 years, males 3.9 years) compared to their normative counterparts (5-8 years).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study showed that at incremental time points throughout childhood, children with CAH collectively follow specific differences in growth trajectories as compared to unaffected children. These variations highlight the need for CAH-specific charts to assist in clinical management, appraisal of growth trajectories, and assessment of the impact of new therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf554","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T11:49:49Z","timestamp":1759578589000},"page":"1125-1135","source":"Crossref","is-referenced-by-count":4,"title":["The Importance of Disease-specific Growth Charts for Children with Congenital Adrenal Hyperplasia"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5741-3629","authenticated-orcid":false,"given":"Kyriakie","family":"Sarafoglou","sequence":"first","affiliation":[{"name":"Division of Pediatric Endocrinology, University of Minnesota Medical School , Minneapolis, MN 55454 ,","place":["USA"]},{"name":"Department of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy , Minneapolis, MN 55455 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yesica","family":"Mercado Munoz","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, University of Minnesota Medical School , Minneapolis, MN 55454 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5105-4475","authenticated-orcid":false,"given":"Charles","family":"Sukin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, National Institutes of Health Clinical Center , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Lteif","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology and Metabolism, Department of Pediatric and Adolescent Medicine, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Kyllo","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Children's Hospitals and Clinics of Minnesota , St. Paul, MN 55102 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3663-5473","authenticated-orcid":false,"given":"Bradley S","family":"Miller","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, University of Minnesota Medical School , Minneapolis, MN 55454 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1269-759X","authenticated-orcid":false,"given":"O Yaw","family":"Addo","sequence":"additional","affiliation":[{"name":"Rollins School of Public Health, Emory University , Atlanta, GA 30322 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3746-0460","authenticated-orcid":false,"given":"Deborah P","family":"Merke","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, National Institutes of Health Clinical Center , Bethesda, MD 20892 ,","place":["USA"]},{"name":"National Institute of Child Health and Human Development Eunice Kennedy Shriver \u00a0 , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"issue":"13","key":"2026031619574811700_dgaf554-B1","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJMra1909786","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"383","author":"Merke","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"2026031619574811700_dgaf554-B2","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1210\/clinem\/dgad134","article-title":"Interpretation of steroid biomarkers in 21-hydroxylase deficiency and their use in disease management","volume":"108","author":"Sarafoglou","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026031619574811700_dgaf554-B3","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jpeds.2014.11.027","article-title":"The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia","volume":"166","author":"Bomberg","year":"2015","journal-title":"J Pediatr"},{"issue":"5","key":"2026031619574811700_dgaf554-B4","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jpeds.2014.01.011","article-title":"Impact of hydrocortisone on adult height in congenital adrenal hyperplasia-the Minnesota cohort","volume":"164","author":"Sarafoglou","year":"2014","journal-title":"J Pediatr"},{"issue":"10","key":"2026031619574811700_dgaf554-B5","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1210\/jc.2009-0942","article-title":"Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation","volume":"94","author":"Bonfig","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026031619574811700_dgaf554-B6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000316973","article-title":"Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone","volume":"75","author":"Bonfig","year":"2011","journal-title":"Horm Res Paediatr"},{"issue":"9","key":"2026031619574811700_dgaf554-B7","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1210\/jc.2009-2616","article-title":"Clinical review: adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis","volume":"95","author":"Muthusamy","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026031619574811700_dgaf554-B8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1067\/mpd.2001.110527","article-title":"Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: a meta-analysis","volume":"138","author":"Eugster","year":"2001","journal-title":"J Pediatr"},{"issue":"5","key":"2026031619574811700_dgaf554-B9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrendo.2013.5","article-title":"Glucocorticoids and the regulation of growth hormone secretion","volume":"9","author":"Mazziotti","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"2026031619574811700_dgaf554-B10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000321244","article-title":"Effects of glucocorticoids on the growth plate","volume":"20","author":"Lui","year":"2011","journal-title":"Endocr Dev"},{"issue":"12","key":"2026031619574811700_dgaf554-B11","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1210\/jc.2012-2102","article-title":"Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia","volume":"97","author":"Finkielstain","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026031619574811700_dgaf554-B12","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/cen.13313","article-title":"Obesity in children with congenital adrenal hyperplasia in the Minnesota cohort: importance of adjusting body mass index for height-age","volume":"86","author":"Sarafoglou","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2026031619574811700_dgaf554-B13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2404655","article-title":"Phase 3 trial of crinecerfont in pediatric congenital adrenal hyperplasia","volume":"391","author":"Sarafoglou","year":"2024","journal-title":"N Engl J Med"},{"issue":"12","key":"2026031619574811700_dgaf554-B14","first-page":"e5247","article-title":"Cardiovascular disease risk factors and metabolic morbidity in a longitudinal study of congenital adrenal hyperplasia","volume":"106","author":"Torky","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026031619574811700_dgaf554-B15","doi-asserted-by":"crossref","first-page":"E1153","DOI":"10.1210\/jc.2014-4033","article-title":"Increased abdominal adiposity in adolescents and young adults with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"100","author":"Kim","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026031619574811700_dgaf554-B16","first-page":"e2022304","article-title":"Growth and Metabolic Syndrome (MetS) criteria in young children with classic Congenital Adrenal Hyperplasia (CAH) treated with corticosteroids (CS)","volume":"93","author":"Abdel Meguid","year":"2022","journal-title":"Acta Biomed"},{"issue":"4","key":"2026031619574811700_dgaf554-B17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00431-017-2875-2","article-title":"Cardio-metabolic risk factors in youth with classical 21-hydroxylase deficiency","volume":"176","author":"Ariyawatkul","year":"2017","journal-title":"Eur J Pediatr"},{"issue":"10","key":"2026031619574811700_dgaf554-B18","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/sim.4780111005","article-title":"Smoothing reference centile curves: the LMS method and penalized likelihood","volume":"11","author":"Cole","year":"1992","journal-title":"Stat Med"},{"issue":"19","key":"2026031619574811700_dgaf554-B19","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1002\/sim.1861","article-title":"Smooth centile curves for skew and kurtotic data modelled using the Box-Cox power exponential distribution","volume":"23","author":"Rigby","year":"2004","journal-title":"Stat Med"},{"key":"2026031619574811700_dgaf554-B20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1651-2227.2006.tb02378.x","article-title":"WHO Child Growth Standards based on length\/height, weight and age","volume":"450","author":"WHO Multicentre Growth Reference Study Group","year":"2006","journal-title":"Acta Paediatr Suppl"},{"key":"2026031619574811700_dgaf554-B21","first-page":"1","article-title":"2000 CDC Growth Charts for the United States: methods and development","volume":"246","author":"Kuczmarski","year":"2002","journal-title":"Vital Health Stat 11"},{"issue":"8","key":"2026031619574811700_dgaf554-B22","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/sim.746","article-title":"Worm plot: a simple diagnostic device for modelling growth reference curves","volume":"20","author":"van Buuren","year":"2001","journal-title":"Stat Med"},{"issue":"6","key":"2026031619574811700_dgaf554-B23","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/jamia\/ocx037","article-title":"Automated identification of implausible values in growth data from pediatric electronic health records","volume":"24","author":"Daymont","year":"2017","journal-title":"J Am Med Inform Assoc"},{"key":"2026031619574811700_dgaf554-B24","volume-title":"Exploratory Data Analysis","author":"Tukey","year":"1977"},{"key":"2026031619574811700_dgaf554-B25","author":"Hales CM, Freedman DS, Akinbami L, Wei R, Ogden CL","year":"2022"},{"issue":"6","key":"2026031619574811700_dgaf554-B26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/03014460.2020.1808065","article-title":"A method for calculating BMI z-scores and percentiles above the 95(th) percentile of the CDC growth charts","volume":"47","author":"Wei","year":"2020","journal-title":"Ann Hum Biol"},{"key":"2026031619574811700_dgaf554-B27","author":"Harrell"},{"key":"2026031619574811700_dgaf554-B28","volume-title":"A Language and Environment for Statistical Computing","author":"R Core Team","year":"2023"},{"issue":"1005","key":"2026031619574811700_dgaf554-B29","first-page":"311","article-title":"Growth patterns and outcomes in congenital adrenal hyperplasia; effect of chronic treatment regimens","volume":"108","author":"Rasat","year":"1995","journal-title":"N Z Med J"},{"issue":"2","key":"2026031619574811700_dgaf554-B30","first-page":"84","article-title":"Growth analysis in patients with 21-hydroxylase deficiency influence of glucocorticoid dosage, age at diagnosis, phenotype and genotype on growth and height outcome","volume":"60","author":"Grigorescu-Sido","year":"2003","journal-title":"Horm Res"},{"issue":"8","key":"2026031619574811700_dgaf554-B31","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1210\/jc.2002-030011","article-title":"Growth inhibition by glucocorticoid treatment in salt wasting 21-hydroxylase deficiency: in early infancy and (pre)puberty","volume":"88","author":"Stikkelbroeck","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026031619574811700_dgaf554-B32","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1046\/j.1365-2265.2002.01645.x","article-title":"Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome","volume":"57","author":"Manoli","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"2026031619574811700_dgaf554-B33","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1515\/jpem-2019-0006","article-title":"Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty","volume":"32","author":"Pijnenburg-Kleizen","year":"2019","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"9","key":"2026031619574811700_dgaf554-B34","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1210\/JC.2015-2093","article-title":"Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a Swedish Population-Based National Cohort Study","volume":"100","author":"Falhammar","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026031619574811700_dgaf554-B35","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1542\/peds.2005-1005","article-title":"Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"117","author":"Vo\u0308lkl","year":"2006","journal-title":"Pediatrics"},{"issue":"4","key":"2026031619574811700_dgaf554-B36","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/cen.12265","article-title":"Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"80","author":"Subbarayan","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"2026031619574811700_dgaf554-B37","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1515\/jpem-2017-0068","article-title":"Cardiovascular and metabolic risk in pediatric patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency","volume":"30","author":"Mooij","year":"2017","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"2026031619574811700_dgaf554-B38","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1542\/peds.2013-0966","article-title":"Adiposity rebound and the development of metabolic syndrome","volume":"133","author":"Koyama","year":"2014","journal-title":"Pediatrics"},{"issue":"3","key":"2026031619574811700_dgaf554-B39","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1542\/peds.101.3.e5","article-title":"Early adiposity rebound and the risk of adult obesity","volume":"101","author":"Whitaker","year":"1998","journal-title":"Pediatrics"},{"issue":"11-12","key":"2026031619574811700_dgaf554-B40","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1159\/000514130","article-title":"Early adiposity rebound predicts obesity and adiposity in youth with congenital adrenal hyperplasia","volume":"93","author":"Bhullar","year":"2021","journal-title":"Horm Res Paediatr"},{"issue":"3","key":"2026031619574811700_dgaf554-B41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/adc.78.3.261","article-title":"Obesity in 21-hydroxylase deficient patients","volume":"78","author":"Cornean","year":"1998","journal-title":"Arch Dis Child"},{"issue":"9","key":"2026031619574811700_dgaf554-B42","doi-asserted-by":"crossref","first-page":"e44893","DOI":"10.1371\/journal.pone.0044893","article-title":"Impact of glucocorticoid receptor gene polymorphisms on the metabolic profile of adult patients with the classical form of 21-hydroxylase deficiency","volume":"7","author":"Moreira","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"2026031619574811700_dgaf554-B43","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1530\/EC-21-0023","article-title":"Hydrocortisone dosing in children with classic congenital adrenal hyperplasia: results of the German\/Austrian registry","volume":"10","author":"Hoyer-Kuhn","year":"2021","journal-title":"Endocr Connect"},{"issue":"10","key":"2026031619574811700_dgaf554-B44","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00467-014-2812-9","article-title":"Growth in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children Study","volume":"29","author":"Rodig","year":"2014","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"2026031619574811700_dgaf554-B45","doi-asserted-by":"crossref","first-page":"e72068","DOI":"10.1371\/journal.pone.0072068","article-title":"Application of body mass index according to height-age in short and tall children","volume":"8","author":"Bonthuis","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"2026031619574811700_dgaf554-B46","doi-asserted-by":"crossref","first-page":"e2063","DOI":"10.1210\/clinem\/dgab051","article-title":"Modified-release hydrocortisone in congenital adrenal hyperplasia","volume":"106","author":"Merke","year":"2021","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf554\/64521920\/dgaf554.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/4\/1125\/64521920\/dgaf554.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/4\/1125\/64521920\/dgaf554.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T23:58:07Z","timestamp":1773705487000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/4\/1125\/8276115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":46,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,10,6]]},"published-print":{"date-parts":[[2026,3,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf554","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2025,10,6]]}}}